OCT Research ULC

Kelowna, British Columbia V1Y 1Z9

2 studies enrolling now · 9 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Depressive Disorder, Major, Dyslipidemias, Hyperlipoproteinemia, Lipid Metabolism Disorders, Menstrual Migraine, Metabolic Diseases, Migraine, Schizophrenia, Treatment Resistant Depression

Studies at this site

• A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine — Recruiting now
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease — Recruiting now
• Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens — Completed
• Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1) — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD — Completed
• A Study of LY3561774 in Participants With Mixed Dyslipidemia — Completed
• A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression — Completed
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early